Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Electrophysiology Therapeutic Devices Market to Grow at a CAGR of 9.3% by 2021: Analysis By Product & End User

Research and Markets
Posted on: 01 Sep 17
Global Electrophysiology Therapeutic Devices Market to Grow at a CAGR of 9.3% by 2021: Analysis By Product & End User

PR Newswire

DUBLIN, September 1, 2017

DUBLIN, September 1, 2017 /PRNewswire/ --

The "Global Electrophysiology Therapeutic Devices Market 2017-2021" report has been added to Research and Markets' offering.

The global electrophysiology therapeutic devices market is forecast to grow at a CAGR of 9.38% during the period 2017-2021.

The report, Global Electrophysiology Therapeutic Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is development of leadless pacemaker. Technological advancements have driven the development of leadless pacemakers. For instance, Nanostim leadless pacemaker developed by St. Jude Medical received the CE mark for the commercial launch in the European market. Leadless pacemakers are developed to reduce the risk of pocket infections, lead dislodgement, fracture or perforation, and extrusion of the pacemaker through the skin.

According to the report, one driver in the market is increasing incidence of cardiac arrhythmia cases. Cardiac arrhythmia is the abnormal rhythm of the heart or irregular heartbeat resulting due to tachycardia (faster heart beat), bradycardia (slower heartbeat), stroke, or cardiac arrest. Cardiac ablation is used as a corrective measure for treating cardiac arrhythmia. EP therapeutic devices are used to monitor the heart beat and facilitate the treatment of the abnormal heart function. The growing incidence of cardiac arrhythmia and CVD cases is driving the growth of many market segments in the EP devices market such as ECG devices, pacemakers, CRT devices, and ablation catheters.

Further, the report states that one challenge in the market is high cost of ablation procedures. Due to technological advances, new tools and techniques are being used for performing ablation procedures in cardiac patients. 3D electro-anatomical mapping and remote catheter monitoring are commonly used during the cardiac ablation procedure. electrophysiologists use robotic technology during the interventional procedures. The magnetic remote monitoring systems are being used in few developed countries with well-equipped healthcare facilities. This system uses magnetic field for assisting navigation of catheters.

Key vendors

  • Boston Scientific
  • Medtronic
  • St. Jude Medical

Other prominent vendors

  • AngioDynamics
  • Biosense Webster
  • BIOTRONIK
  • Cardiac Science
  • Cook Medical
  • GE Healthcare
  • Others

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By End-User

Part 08: Geographical Segmentation

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Key Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/3sv2mx/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-electrophysiology-therapeutic-devices-market-to-grow-at-a-cagr-of-93-by-2021-analysis-by-product--end-user-300512949.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 01/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.